Rapid Point-of-Care Salivary Diagnostic for Periodontal Health
NCT ID: NCT02403297
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
93 participants
OBSERVATIONAL
2015-03-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Microfluidic System for Oral Diagnostics
NCT00277745
Apoptic Biomarkers of Periodontal Disease
NCT00569075
Effect of Periodontal Treatment on Salivary Biomarkers
NCT02159781
Diagnostic Biomarkers Related to Periodontal Disease Activity in Diabetic
NCT02220751
Evaluating Gingivitis and Systemic Biomarkers
NCT06962956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Three groups of individuals will be recruited: those that are orally healthy and do not have any oral discomfort (N=58), those who have gingivitis (i.e., bleeding gums; N=58), and those who have periodontal disease (N=58). The groups will be matched by gender and smoking status. Women are predicted to account for 50% of the participants. The age distribution will be 18 to 95 years. Subjects will not be excluded based on race, gender, or ethnicity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Saliva will be collected from 58 subjects determined to be "healthy" according to the protocol.
Quik Check PD
The device is not an intervention. It is a device to determine if MMP-8 is present in a subjects saliva.
Gingivitis
Saliva will be collected from 58 subjects determined to have gingivitis according to the protocol.
Quik Check PD
The device is not an intervention. It is a device to determine if MMP-8 is present in a subjects saliva.
Periodontal disease
Saliva will be collected from 58 subjects determined to have periodontal disease according to the protocol.
Quik Check PD
The device is not an intervention. It is a device to determine if MMP-8 is present in a subjects saliva.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quik Check PD
The device is not an intervention. It is a device to determine if MMP-8 is present in a subjects saliva.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 20 erupted teeth and the ability to provide expectorated saliva;
* Able and willing to comply with study requirements; and
* Have full understanding of all elements of, and signature and dating of the written informed consent prior to the initiation of protocol specified procedures
Exclusion Criteria
* Persons with acute illness or infectious disease (as evidenced by fever, malaise, sore throat, recurrent cough, lymphadenopathy, swelling and/or a physician consultation);
* Evidence of oral mucosal lesion or ulceration; or
* Use of glucocorticoids or cyclooxygenase inhibitors (i.e. such as ibuprofen, Naprosyn(Aleve) or non-steroidal anti-inflammatory drug) daily for the past two weeks.
18 Years
95 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Diagnostics Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Innovative Diagnostics Inc
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-1R43DE024015-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.